ASRS
AKRO

Arizona State Retirement System’s Akero Therapeutics AKRO Stock Holding History

Arizona State Retirement System’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,503
Closed -$784K – 2052
2025
Q3 		$784K Buy
16,503
+257
+2% +$12.4K ﹤0.01% 1263
2025
Q2 		$867K Buy
16,246
+2,257
+16% +$103K 0.01% 1174
2025
Q1 		$566K Sell
13,989
-86
-0.6% -$3.65K ﹤0.01% 1365
2024
Q4 		$392K Buy
14,075
+136
+1% +$4.12K ﹤0.01% 1620
2024
Q3 		$400K Sell
13,939
-581
-4% -$15.1K ﹤0.01% 1604
2024
Q2 		$341K Sell
14,520
-121
-0.8% -$2.59K ﹤0.01% 1642
2024
Q1 		$370K Buy
14,641
+2,206
+18% +$53K ﹤0.01% 1611
2023
Q4 		$290K Sell
12,435
-167
-1% -$3.29K ﹤0.01% 1739
2023
Q3 		$637K Buy
12,602
+170
+1% +$7.92K 0.01% 1243
2023
Q2 		$580K Buy
12,432
+3,625
+41% +$166K ﹤0.01% 1326
2023
Q1 		$337K Buy
8,807
+505
+6% +$22.5K ﹤0.01% 1635
2022
Q4 		$455K Buy
+8,302
New +$356K ﹤0.01% 1425

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Arizona State Retirement System's AKRO Position: Q4 2025 in Review

Arizona State Retirement System sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 16,503 shares — an estimated $784K sold.

Arizona State Retirement System first reported a position in AKRO in Q4 2022 and held it in 12 quarters. The position peaked at $867K in Q2 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • Arizona State Retirement System reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Arizona State Retirement System sold 16,503 Akero Therapeutics shares in Q4 2025, an estimated $784K.
  • Arizona State Retirement System first reported a position in Akero Therapeutics in Q4 2022 and held it in 12 quarters.
  • Arizona State Retirement System's Akero Therapeutics position peaked at $867K in Q2 2025.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Arizona State Retirement System's 13F filing for Q4 2025, filed 28 Jan 2026.